International Journal of Clinical Research

Objective To analyze the effect of modified transvaginal pelvic organ prolapse surgery in the clinical treatment of patients with pelvic organ prolapse. Methods A total of 40 patients with pelvic organ prolapse admitted to our hospital from January to December 2023 were set as the observation group, and patients who underwent vaginal hysterectomy and vaginal wall repair from 2021 to 2022 were retrospectively analyzed as the control group to compare the clinical efficacy of the two groups. Results There was no statistically significant difference in the average length of hospital stay, treatment costs, and postoperative vaginal length between the two groups (P>0.05). However, the operation time of the observation group was shorter than that of the control group, and the intraoperative blood loss and the total recurrence rate at 3 months, 6 months, and 12 months after surgery were lower than those of the control group, and the differences were statistically significant (P<0.05). Conclusion The modified transvaginal pelvic organ prolapse surgery has a good effect, can optimize the clinical indicators of patients, improve prognosis, reduce postoperative recurrence, and has a good application effect.

Modified transvaginal pelvic organ prolapse surgery; Pelvic organ prolapse; Clinical efficacy; Quality of life